Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial (2018)
Fonte: Journal of the American College of Cardiology. Unidade: HU
Assuntos: CARDIOPATIAS, BETA-BLOQUEADORES, HIDROCARBONETOS POLICÍCLICOS, QUIMIOTERAPIA, TOXICOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AVILA, Mônica Samuel et al. Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial. Journal of the American College of Cardiology, v. 71, n. 20, p. 2281-2290, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.02.049. Acesso em: 11 nov. 2024.APA
Avila, M. S., Ayub-Ferreira, S. M., Wanderley Júnior, M. R. de B., Cruz, F. das D., Brandão, S. M. G., Rigaud, V. O. C., et al. (2018). Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial. Journal of the American College of Cardiology, 71( 20), 2281-2290. doi:10.1016/j.jacc.2018.02.049NLM
Avila MS, Ayub-Ferreira SM, Wanderley Júnior MR de B, Cruz F das D, Brandão SMG, Rigaud VOC, Santos MHH dos, Hajjar LA, Kalil Filho R, Hoff PM, Sahade M, Ferrari MSM, Costa RL de P, Mano MS, Cruz CBBV, Abduch MC, Alves MSL, Guimarães GV, Issa VS, Bittencourt MS, Bocchi EA. Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial [Internet]. Journal of the American College of Cardiology. 2018 ; 71( 20): 2281-2290.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.jacc.2018.02.049Vancouver
Avila MS, Ayub-Ferreira SM, Wanderley Júnior MR de B, Cruz F das D, Brandão SMG, Rigaud VOC, Santos MHH dos, Hajjar LA, Kalil Filho R, Hoff PM, Sahade M, Ferrari MSM, Costa RL de P, Mano MS, Cruz CBBV, Abduch MC, Alves MSL, Guimarães GV, Issa VS, Bittencourt MS, Bocchi EA. Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial [Internet]. Journal of the American College of Cardiology. 2018 ; 71( 20): 2281-2290.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.jacc.2018.02.049
